Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Sanofi Aventis
Scientific Title
A Randomized, Multicenter, Double-blind Phase 3 Study of SAR439859 Plus Palbociclib Versus Letrozole Plus Palbociclib for the Treatment of Patients With ER (+), HER2 (-) Breast Cancer Who Have Not Received Prior Systemic Anti-cancer Treatment for Advanced Disease